SCHEMBL6280419

SCHEMBL6280419

O=C1C(=O)N(CCCCBr)c2ccc(C3CCCCC3)cc21

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.42
BCHE P06276 1/20 0.42
CASP3 P42574 9/20 0.40
CASP7 P55210 9/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH2 P05091 1/20 0.39
ALDH3A1 P30838 1/20 0.39
CASP1 P29466 2/20 0.39
CASP6 P55212 1/20 0.39
CDC25A P30304 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050379 0.79 MAOB (0.55) BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL4503347 0.78 MAOB (0.56) CES1BCHECDC25A
SCHEMBL6284754 0.77 MAOB (0.45) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL11147994 0.76 ALDH1A1 (0.62) CES1BCHEALDH1A1MEN1POLB
SCHEMBL11149802 0.75 PARK7 (0.62) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL29011259 0.75 ALDH3A1 (0.60) CES1BCHEALDH1A1ALDH2ALDH3A1
SCHEMBL29011247 0.75 ALDH1A1 (0.60) CES1BCHEALDH1A1MEN1POLB
SCHEMBL11147281 0.75 ALDH1A1 (0.65) CES1BCHEALDH1A1MEN1POLB
SCHEMBL6284752 0.74 CES1 (0.40) CES1BCHECASP3CASP7ALDH1A1
SCHEMBL9096146 0.74 DRD2 (0.55) CASP3CASP7ALDH1A1ALDH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6906090-B1 Compositions and methods for treating mycobacterial diseases ASTRAZENECA AB (SE) 2005-06-14 US claimed
EP-1058548-B1 THE USE OF ISATIN AND OXINDOLE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR USE IN THE TREATMENT OF MYCOBACTERIAL DISEASE ASTRAZENECA AB (SE) 2003-09-17 EP claimed
EP-1058548-A1 NEW USE AstraZeneca AB (SE) 2000-12-13 EP claimed
WO-1999044608-A1 NEW USE ASTRAZENECA AB (SE) 1999-09-10 WO claimed
US-6906090-B1 Compositions and methods for treating mycobacterial diseases ASTRAZENECA AB (SE) 2005-06-14 US disclosed
EP-1058548-B1 THE USE OF ISATIN AND OXINDOLE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR USE IN THE TREATMENT OF MYCOBACTERIAL DISEASE ASTRAZENECA AB (SE) 2003-09-17 EP disclosed
EP-1341849-A1 POLYAMIDE MOULDING MATERIAL WITH IMPROVED PROPERTIES EMS-Chemie AG (CH) 2003-09-10 EP disclosed
WO-2002040591-A1 POLYAMIDE MOULDING MATERIAL WITH IMPROVED PROPERTIES EMS-CHEMIE AG (CH) 2002-05-23 WO disclosed
EP-1058548-A1 NEW USE AstraZeneca AB (SE) 2000-12-13 EP disclosed
WO-1999044608-A1 NEW USE ASTRAZENECA AB (SE) 1999-09-10 WO disclosed
EP-0703901-A1 1-SUBSTITUTED ISATIN AND OXINDOLE DERIVATIVES AS INHIBITORS OF ACETYLCHOLINESTERASE Astra Aktiebolag (SE) 1996-04-03 EP disclosed
WO-1994029272-A1 1-SUBSTITUTED ISATIN AND OXINDOLE DERIVATIVES AS INHIBITORS OF ACETYLCHOLINESTERASE ASTRA AKTIEBOLAG (SE) 1994-12-22 WO disclosed